Literature DB >> 15317727

Macular infarction after intravitreal amikacin: authors' reply.

G D Galloway, A Ramsay, K Jordan, A Vivian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15317727      PMCID： PMC1772327          DOI： 10.1136/bjo.2004.042838

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

1.  Macular infarction after intravitreal amikacin: mounting evidence against amikacin.

Authors:  G Galloway; A Ramsay; K Jordan; A Vivian
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

2.  Macular infarction after intravitreal amikacin.

Authors:  B H Doft; M Barza
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

3.  An in vitro study of ceftazidime and vancomycin concentrations in various fluid media: implications for use in treating endophthalmitis.

Authors:  Alvin K H Kwok; Mamie Hui; Chi Pui Pang; Raphael C Y Chan; Siu Wai Cheung; Cynthia M S Yip; Dennis S C Lam; Augustine F B Cheng
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-04       Impact factor: 4.799

4.  Intraocular kinetics of ceftazidime (Modacin).

Authors:  K Mochizuki; Y Yamashita; M Torisaki; M Komatsu; T Tanahashi; K Kawasaki
Journal:  Ophthalmic Res       Date:  1992       Impact factor: 2.892

5.  In vitro activity of ceftazidime in combination with other antibiotics.

Authors:  C Simon; G Littschwager
Journal:  Infection       Date:  1985 Jul-Aug       Impact factor: 3.553
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.